CTXR has been granted a new patent
Nov 27, 2024, 11:37 PM
-8.06%
What does CTXR do
Citius Pharmaceuticals, based in Cranford, NJ, specializes in critical care products, particularly in oncology and anti-infectives. Its key products include LYMPHIR, Mino-Lok, Halo-Lido, Mino-Wrap, and NoveCite.
CTXR filed a patent for "halobetasol propionate-lidocaine formulations" on Thu, April 27, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.